4.8 Article

LipoBots: Using Liposomal Vesicles as Protective Shell of Urease-Based Nanomotors

Journal

ADVANCED FUNCTIONAL MATERIALS
Volume 30, Issue 42, Pages -

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adfm.202002767

Keywords

enzyme catalysis; liposomes; nanomotors; self-propulsion

Funding

  1. Spanish MINECO (BOTSinFluids project)
  2. Foundation BBVA (MEDIROBOTS project)
  3. CERCA program by the Generalitat de Catalunya
  4. CaixaImpulse program by La Caixa Foundation (TERANOBOTS project)
  5. MINECO for the Severo Ochoa PhD fellowship
  6. European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie Individual Fellowship (H2020-MSCA-IF2018)
  7. Catalan AGAUR [2017 SGR 238]
  8. CERCA Program/Generalitat de Catalunya
  9. Severo Ochoa program from the Spanish MINECO [SEV-2017-0706]

Ask authors/readers for more resources

Developing self-powered nanomotors made of biocompatible and functional components is of paramount importance in future biomedical applications. Herein, the functional features of LipoBots (LBs) composed of a liposomal carrier containing urease enzymes for propulsion, including their protective properties against acidic conditions and their on-demand triggered activation, are reported. Given the functional nature of liposomes, enzymes can be either encapsulated or coated on the surface of the vesicles. The influence of the location of urease on motion dynamics is first studied, finding that the surface-urease LBs undergo self-propulsion whereas the encapsulated-urease LBs do not. However, adding a percolating agent present in the bile salts to the encapsulated-urease LBs triggers active motion. Moreover, it is found that when both types of nanomotors are exposed to a medium of similar pH found in the stomach, the surface-urease LBs lose activity and motion capabilities, while the encapsulated-urease LBs retain activity and mobility. The results for the protection enzyme activity through encapsulation within liposomes and in situ triggering of the motion of LBs upon exposure to bile salts may open new avenues for the use of liposome-based nanomotors in drug delivery, for example, in the gastrointestinal tract, where bile salts are naturally present in the intestine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available